← FDA DRUG APPROVALS

FDA ANDA · ANDA203736

FLUDEOXYGLUCOSE F18

Sponsor: MIDWEST MEDCL

APPLICATION
ANDA203736
TYPE
ANDA
ORIGINAL APPROVAL
2015-11-19
LATEST ACTION
2015-11-19
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FLUDEOXYGLUCOSE F18Discontinued
FLUDEOXYGLUCOSE F-18 20-200mCi/ML · INJECTABLE · INTRAVENOUS

Approval history

2015-11-19UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →